Patents by Inventor Christian Bloy

Christian Bloy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating glutamate cytotoxicity with beta-naphthoquinone compounds
    Patent number: 7572774
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: August 11, 2009
    Assignee: Centre National de la Recherche Scientific (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and/or the treatment of glutamate cytotoxicity
    Publication number: 20070225237
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and /or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: May 11, 2007
    Publication date: September 27, 2007
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and/or the treatment of glutamate cytotoxicity
    Publication number: 20070225236
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: May 11, 2007
    Publication date: September 27, 2007
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and/or the treatment of glutamate cytotoxicity
    Publication number: 20070225235
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: May 11, 2007
    Publication date: September 27, 2007
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and / or the treatment of glutamate cytotoxicity
    Publication number: 20020115617
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoguinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: January 22, 2002
    Publication date: August 22, 2002
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Method for inhibiting blood-platelet aggregration with .beta.-naphthoquinone compounds
    Patent number: 5523322
    Abstract: A method of inhibiting blood-platelet aggregation in warm-blooded animals comprising administering to warm-blooded animals a blood-platelet aggregation inhibiting effective amount of a compound selected from the group consisting of a compound of the formula ##STR1## wherein R is selected from the group consisting of --NH--CO--NH.sub.2, --NH--CO--CH.sub.3, --OH and their non-toxic, pharmaceutically acceptable acid addition salts.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: June 4, 1996
    Assignee: Roussel UCLAF
    Inventors: Denis Blache, Christian Bloy, Bernard Hercelin
  • Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases
    Patent number: 5478821
    Abstract: A method of accelerating the proliferation of endothelial cells with inhibition of NO synthases in warm-blooded animals comprising administering to warm-blooded animals an amount of at least one compound selected from the group consisting of a .beta.-naphthoquinone of the formula ##STR1## wherein R is selected from the group consisting of --NH--CO--NH.sub.2, --NH--C0--CH.sub.3 and --0H and their non-toxic, pharmaceutically acceptable acid addition salts in an amount sufficient to accelerate the proliferation of endothelial cells.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: December 26, 1995
    Assignee: Roussel UCLAF
    Inventors: Christian Bloy, Jean-Pierre Cazenave, Bernard Hercelin, Bernard Teisseire